Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors
Clinical trial NCT05287399 · COMPLETED
Trial details
- NCT number
- NCT05287399
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2025-01-17
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.